VISIONAIRE PRODUCTS, INC

Urbana, IL · Medtech · Private

A medical device for collecting ocular fluid (aqueous humor) from the eye using an optimized needle and microfluidic chamber for diagnostic biopsies

Grants
$1.7M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
4
0 granted · 4 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: A novel, microfluidic device to improve collection and analysis of biopsy samples from ocular paracentesis$256,000
Federal grantNational Science Foundation · Phase II · SBIR Phase II:A novel, microfluidic device to improve collection and analysis of biopsy samples from ocular paracentesis$1,399,997
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1971CELEFLUX LLC——
1972Vizgen—$295M
1973Navan Technologies Inc.——
1974VISIONAIRE PRODUCTS, INC——
1975REFER2INPUT, LLC——
1976CADUCEUS WIRELESS, INC.——
1977NEUROBEHAVIORAL RESEARCH, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 4
  • Needle And Collection Device For Ocular Biopsy And Methods Of Useapplication
  • Needle And Collection Device For Ocular Biopsy And Methods Of Useapplication
  • Novel Needle And Collection System For Ocular Fluid Biopsy And Methods Of Useapplication
  • Toddler Urinalapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.